|Year : 2011 | Volume
| Issue : 2 | Page : 176-180
Seroprevalence of Chlamydia trachomatis in Enugu, Nigeria
AC Ikeme1, HU Ezegwui2, LC Ikeako3, I Agbata3, E Agbata1
1 Department of Obstetrics and Gynaecology, University of Nigeria Teaching Hospital, Enugu, Nigeria
2 Department of Obstetrics and Gynaecology,Anambra StateUniversity Teaching Hospital, Amaku, Awka, Nigeria
3 Department of Microbiology, University of Nigeria Teaching Hospital, Enugu, Nigeria
|Date of Acceptance||10-Mar-2011|
|Date of Web Publication||19-Aug-2011|
H U Ezegwui
Department of Obstetrics and Gynaecology, University of Nigeria Teaching Hospital, Enugu
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Chlamydia infections in women cause pelvic inflammatory disease, which often results in devastating consequences of infertility, ectopic pregnancy, or chronic pelvic pain. The infection is largely asymptomatic.
Objective: To determine the seroprevalence of Chlamydia trachomatis in Enugu, South Eastern Nigeria.
Materials and Methods: A population-based prospective study comprising female residents of Enugu, South Eastern Nigeria. Indirect solid phase enzyme immunoassay of Chlamydia antibodies was done using ImmunoComb C0. Trachomatis IgG Kit (Orgenics).
Results: The population comprised 136 female undergraduate students and 150 non-student women. The overall prevalence of C. trachomatis in the population studied was 29.4%. The percentage of subjects who admitted to be having multiple sexual partners was higher among the student population (71.2%) compared to those from the non-student population (28.8%). The highest percentage of seroprevalence was 28 (33.3%) in the age group of 20-24 years for the student population and 18 (21.4%) in the age group of 25-29 years for the non-student population. The highest seroprevalence of C. trachomatis antibodies (69.0%) in both populations was observed in females without any history of infection. Females that had pelvic inflammatory disease, sexually transmitted infection, and secondary infertility assayed for C. trachomatis had seroprevalence levels of 19%, 9.5%, and 2.4%, respectively. There was a positive correlation between positive Chlamydia assay and the type of subject population (student or non-student) with r2 value of 1.55 at P < 0.01.
Conclusions: C. trachomatis infection is largely underdiagnosed and remains a silent disease in the apparently healthy population of Enugu, South eastern Nigeria.
Keywords: Chlamydia trachomatis , infection, seroprevalence
|How to cite this article:|
Ikeme A C, Ezegwui H U, Ikeako L C, Agbata I, Agbata E. Seroprevalence of Chlamydia trachomatis in Enugu, Nigeria. Niger J Clin Pract 2011;14:176-80
|How to cite this URL:|
Ikeme A C, Ezegwui H U, Ikeako L C, Agbata I, Agbata E. Seroprevalence of Chlamydia trachomatis in Enugu, Nigeria. Niger J Clin Pract [serial online] 2011 [cited 2016 Oct 26];14:176-80. Available from: http://www.njcponline.com/text.asp?2011/14/2/176/84010
| Introduction|| |
With an estimated 90 million cases worldwide, Chlamydia trachomatis is a major causative agent of sexually transmitted disease (STD). 
C. trachomatis is an obligate intracellular bacterium with 15 immunotypes, which are as follows: Types A-C cause trachoma (chronic conjunctivitis endemic in Africa and Asia); D-K cause genital tract infections; and serotypes L1-L3, Lymphogranuloma venereum (associated with genital ulcer disease in tropical countries).
Genital infection caused by C0. trachomatis is generally asymptomatic. Approximately 50% of infected males and 80% of infected females show no symptoms, but infection may cause a mucopurulent cervicitis in females and urethritis in males.  Commonly unrecognized and often poorly or inadequately treated, Chlamydia infections can ascend the reproductive tract resulting in pelvic inflammatory disease (PID) and, consequently, lead to chronic pelvic pain, ectopic pregnancy, and infertility. 
Women with a Chlamydia infection (especially serotype G) are 6.5 times more likely to develop cervical cancer than those without infection.  In women with recent or invasive Chlamydia infection, indicated by the presence of 1 gM antibody against C. trachomatis, increased rates of preterm delivery, premature rupture of membranes, low birth weight, and still birth have been observed.  Infection with C. trachomatis is also implicated in postabortal, post Cesarean section, and postpartum maternal infections.
C. trachomatis in the cervix may be transmitted to a neonate during vaginal delivery, resulting in conjunctivitis and neonatal pneumonia. Chlamydia infection develops in 60% of neonates born vaginally to infected mothers and untreated neonatal conjunctivitis can lead to blindness. 
Premarital sexual intercourse and intercourse with multiple partners have been shown to be significant risk factors for C. trachomatis as well as HIV infection.  The invasive intracellular pathogenesis of C. trachomatis can cause significant damage to the genital epithelial layer, which may facilitate HIV infection. Conversely, the immunological changes due to HIV infection may favor C. trachomatis infection. 
Methods of testing for Chlamydia include cell culture, direct fluorescent antibody, enzyme immunoassay, and the newer nucleic acid amplification technique. There is a wide variation in the costs, sensitivities, and specificities of these methods.
Owing to varied characteristics of the study population and different methods used for Chlamydia detection, there is a wide variation in prevalence rates of Chlamydia infection. , Approximately 4 million cases of Chlamydia infection are reported per year in the US, with an overall prevalence of 5%.  In Ethiopia,  the prevalence rate for Chlamydia infection of the cervix was 5.9%. Low gravidity and age <30 years were independently significant risk factors for cervical antigen positivity. Among unsuspecting women attending antenatal clinic in Benin City, Nigeria,  a prevalence rate of 13.3% was noted, while Nwanguma et al. reported a prevalence of 33% in asymptomatic volunteers in a population of Nigerians living in two cities in the South Eastern part of the country.
However, morbidity caused by the sub-clinical nature of Chlamydia infection has been recognized in developed countries and screening methods adopted to prevent consequences of untreated infection such as PID, the same cannot be said of the developing societies because reliable assays are too expensive and complex for routine use. ,
Brunham et al. suggested that in the absence of strategies to alter sexual network, vaccine would be needed to halt spread of infection at the population level.
This study was conducted to estimate the prevalence of C0. trachomatis infection in Enugu and South-Eastern Nigeria, as well as suggest ways to limit the spread and complications of this largely asymptomatic disease.
| Materials and Methods|| |
This was a population-based prospective study conducted at University of Nigeria Teaching Hospital, Enugu, South-Eastern Nigeria, over a 3-month period.
Enugu, an old regional capital has a population of 717,291 according to the 2006 national census figure. Over the past two decades, Enugu has undergone rapid urbanization. The major occupations include civil service, trading, and animal husbandry by the Hausa minority at the periphery of the town. The major ethnic group is the Ibos.
The study group (non-Student) comprised 150 women aged 20-34 years attending the gynecological clinic for secondary infertility, PID, and STD.
The control group comprised 136 female undergraduate volunteers in the same age bracket.
For all participants, a standardized questionnaire, which gathered demographic and behavioral information such as age, marital status, and number of sex partners was completed.
Only those who had not been on azithromycin, erythromycin, doxycycline, or tetracycline in the past three months before sampling were included in the study. Each subject gave her consent and the study was approved by the Ethical Committee of the hospital. Data were analyzed using tables and simple percentages. Chi-square test was used to compare the variables and P ≤ 0.05 was considered statistically significant.
Venous blood was aseptically collected from the antecubital fossa or dorsal veins of the arm of 286 female subjects into clean plain test tubes. The blood samples were allowed to clot and centrifuged at 3,000 rpm (Hettich Universal). Thereafter, the sera were separated into plain bottles and preserved at 2-8 o C. The materials used included ImmunoComb Chlamydia trachomatis IgG kit (Orgenics) and precision pipette.
The solid phase is a comb with 12 projections (teeth); each tooth is sensitive at two positions-an upper and a lower spot.
At the start of the test, serum specimens were added to the diluents in the wells of row A of the developing plate. The comb was then inserted into the wells of row A. Anti-C. trachomatis antibodies, if present in the specimens, will specifically bind to respective Chlamydia antigens on the lower spot of each tooth of the comb. Simultaneously, immunoglobulins present in the specimens were captured by the anti-human immunoglobulin on the upper spot (internal control). Unbound components were washed away in row B. In row C, the human IgG captured on the teeth will react with alkaline phosphatase-labeled anti-IgG. In the next two rows, unbound components were removed by washing.
In row F, the bound alkaline phosphatase will react with chromogenic components. The results were visible as gray-blue spots on the surface of the teeth of the comb.
All components, developing plates, reagents, and specimens were brought to room temperature (25 o C) and the tests were performed at room temperature.
Row A of the developing plate was perforated and 0.10 ml of each serum sample was placed into the wells using a micropipette and mixed repeatedly and the pipette tip discarded. The comb was then inserted into the wells of row A containing the specimens, mixed several times and incubated at room temperature for 10 minutes in row A. Towards the end of 10 minutes, the foil of row B was perforated, the comb was removed from row B and the adhering liquids from the tips of the teeth absorbed on a clean absorbent paper. The comb was inserted into the wells of row B and agitated for 2 minutes. Row C was perforated and the comb transferred into the wells and allowed to stand for 20 minutes. It was absorbed and inserted into row D for 2 minutes and row E for 2 minutes. The comb was inserted in row E for one minute for a stop reaction and then allowed to dry in air. The controls were carried along with the test.
| Results|| |
[Table 1] shows the age distribution of the subjects. The total distribution of subjects with respect to age was as follows: 120 of 286 subjects (42.0%) were observed for age groups of 20-24 and 25-29 years, whereas 46 of 286 subjects (16.1%) were observed for the age group of 30-34 years (χ2 = 65.530, P < 0.001). The correlation between age and type of subject was significant (P < 0.01), correlation coefficient r2 = 0.477.
Similarly, the demography of the 286 study population showed that 218 were single and 68 were married. Of the 218 singles population, 124 (56.9%) were from the student population, while 94 (43.1%) were from the non-student population. Age and marital status of the subjects significantly correlated at P < 0.01, r2 = 0.408.
The percentage of subjects who admitted having multiple sexual partners was higher among the student population (71.2%) compared with those from the non-student population (28.8%).
The seroprevalence of positive Chlamydia antibodies assay with respect to age in relation to the type of subject population is shown in [Table 2]. The highest percentage seroprevalence was 28 (33.3%) within the age group of 20-24 years and 18 (21.4%) in the age group of 25-29 years for student and non-student population, respectively. The c2 value for Chlamydia assay seropositivity was 9.751 at P < 0.01.
|Table 2: Distribution of positive Chlamydia antibodies with respect to age and type of subject population |
Click here to view
The overall percentage seroprevalence for positive Chlamydia antibodies in both populations was 36 (42.9%) each for the age groups of 20-24 years and 25-29 years and 12 (14.2%) for age group of 30-34 years. Matched age for age, there was a significant positive correlation between positive Chlamydia assay and the type of subject populations with r2 value of 0.155 at P < 0.01.
In [Table 3], of the subjects with positive results, an incidence of 17.5% was observed in the student population, while 11.9% incidence was recorded for the non-student population. The χ2 value for the summary of the incidence of Chlamydia antibodies in relation to subject population was 6.834 at P < 0.01.
|Table 3: Summary of Chlamydia antibodies assay result in relation to the subject |
Click here to view
[Table 4] reveals the seroprevalence of positive Chlamydia antibodies with respect to subjects and type of infection or gynecological condition. It demonstrated that out of 84 sera obtained from both population, which tested positive for Chlamydia antibodies, 58 (69.0%) were observed in apparently healthy females assayed routinely, while 16 (19.0%), 8 (9.55%), and 2 (2.4%) were observed in females with PID, STD, and secondary infertility, respectively.
|Table 4: Seroprevalence of positive Chlamydia with respect to age in relation to provisional diagnosis of subject population |
Click here to view
The highest seroprevalence rate of 69.0% observed in routine assays showed a distribution of 34 (40.5%), 20 (23.8%), and 4 (4.8%) in the age groups of 20-24 years, 25-29 years, and 30-34 years, respectively.
Pearson Chi-square tests of relationship between provisional diagnosis and prevalence of Chlamydia antibodies showed c2 = 30.695 at P < 0.001. There was a significantly positive correlation between age and provisional diagnosis with r2 value of 0.45% at P < 0.01.
The relationship between the type of subject population (student and non-student) and provisional diagnosis was significant, with r2 value of 0.614 at P < 0.01. However, no significant correlation was observed between positive Chlamydia and provisional diagnosis.
| Discussion|| |
This study demonstrated that asymptomatic women tested positive for Chlamydia more than women attending a gynecological clinic for PID, STD, and secondary infertility. This is surprising, as these conditions should usually be associated with increased incidence of reproductive tract complication arising from Chlamydia infection.
The diagnosis of C. trachomatis has been problematic due to labor-intensive culture techniques. The method used in this study has been documented as an inexpensive and effective screening method in developing countries. , The more accurate test like nucleic acid amplification for detection of infected genital secretions was not available. A case is hereby made for more networking between the developed and developing world in the provision of these more accurate test kits. It will in the long run be more profitable both in the research and management of patients.
There is a wide regional variation in the incidence of C. trachomatis and this variation depends on the age, marital status, clinical condition, sensitivities of the methods used, and various other factors. ,
The Chlamydia assay result in relation to the subject population (student and non-student) found in this study showed a 29.4% positive incidence of C. trachomatis infections, while 70.6% were negative in both populations. This result showed a high incidence of asymptomatic C. trachomatis, which agrees with findings of other reports. ,
This study also revealed that the overall seroprevalence of positive C. trachomatis was higher in the student population than in the non-student population. This is in agreement with the previously reported association of C. trachomatis infection with young age groups.  This may indicate higher sexual activity, multiple sexual partners, and low or no use of barrier (condom) method of contraception that is prevalent in this group. 
In this study, the majority of patients who were positive to C. trachomatis were tested routinely during a sexually transmitted infection and general gynecological clinic and were not associated with a diagnosis of PID, STD, and secondary infertility. This finding is in agreement with previously reported data, which indicated that 70% of Chlamydia-associated genital infections are asymptomatic.  The asymptomatic infections are pivotal to persistence and ongoing transmission on a population level. 
Widespread utilization of more accurate tests like nucleic acid amplification for detection of infected genital secretions in those attending the sexually transmitted infection or general gynecological clinics for infertility, whether symptomatic or asymptomatic, should still be practiced, especially in developing countries. This is perhaps a better way of detecting and treating asymptomatic C. trachomatis, which is still highly prevalent in apparently healthy population, especially the more sexually active student population.
This is perhaps a prospective useful epidemiological eradication measure for the control of C. trachomatis infection. Other measures, such as the use of barrier method during sexual intercourse, limiting the number of sexual partners, public awareness, school involvement, and peer educators may also help in reducing the incidence and prevalence of this infection.
Chlamydia infection remains largely underdiagnosed and a silent disease in apparently healthy populations in developing countries.
| References|| |
|1.||World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections. Overview and estimates. Geneva: WHO; 2001. |
|2.||Ingalis RR, Rice PA, Qureshi N, Takayama K, Lin JS, Golenback DT. The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated. Infect Immun 1995;63:3125-30. |
|3.||Chernesky MA. The laboratory diagnosis of Chlamydia trachomatis infection. Can J Infect Dis Med Microbiol 2005;16:39-44. |
|4.||Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikäheimo I. Serotypes of Chlamydia trachomatis and risk development of cervical squamous cell carcinoma. JAMA 2001;285:47-51. |
|5.||McGregor JA, French JI. Chlamydia trachomatis infection during pregnancy. Am J Obstet Gynecol 1991;164:1782-9. |
|6.||Darville T. Chlamydia trachomatis infections in neonates and young children. Semin Pediatr Infect Dis 2005;16;235-44. |
|7.||Hitchcock PJ. Future directions of Chlamydial research In: Stephens RS, editor. Chlamydia intracellular biology. Pathogenesis and immunity. Washington DC: American Society for Microbiology;1999 p. 297-311. |
|8.||Debattista J, Clementson C, Mason D, Dwyer J, Argent S, Woodward C, et al. Screening for Neisseria gonorrhoea and Chlamydia trachomatis at entertainment venues among men who have sex with men. Sex Transm Dis 2002;29:216-21. |
|9.||Verkoyeen RP, Peeter MF, Van Rijsoort-Vos JH, van der Meijden WI, Marton JW. Sensitivity and specificity of three new commercially available Chlamydia trachomatis tests. Int J STD AIDS 2002;2:23-5. |
|10.||Buve A, Weiss HA, Laga M, Van Dyck E, Musonda R, Zekeng L, et al. The epidemiology of gonorrhea, Chlamydia infection and syphilis in four African countries. AID 2001;15:579-88. |
|11.||Centres for Disease Control and Prevention. Chlamydia screening among sexually active young female enrollees of health plans-United States 2000-2007. MMWR Morb Mortal Wkly Rep 2009;58:362-5. |
|12.||Isibor JO, Ugbomoiko D, Nwobu GO, Ekundayo AO, Eweani IB, Okogun GR. Detection of Chlamydial Antigen in cervical specimens from antenatal clinic attendee in Benin City, Nigeria. Af J Clin Exp Microbiol 2005;6:208-11. |
|13.||Nwanguma BC, Kalu I, Ezeanyika LU. Seroprevalence of anti-Chlamydia trachomatis IgA antibody in a Nigeria Population: Diagnostic significance and implications for the heterosexual transmission of HIV. Int J Infect Dis 2009;7:2. |
|14.||Peiperrt JF. Clinical Practice Genital Infections N Engl J Med 2003;349:2424-30. |
|15.||Seimer J, Theile O, Larbi Y, Fasching PA, Danso KA, Kreienberg R, et al. Chlamydia trachomatis infection as a risk factor for fertility among women in Ghana, West Africa. Am J Trop Med Hyg 2008;78:323-7. |
|16.||Brunham RC, Pourbohloul B, Mak S, White R, Rekart ML. The unexpected impact of Chlamydia trachomatis infection control program on susceptibility to reinfection. J Infect Dis 2005;192:1836-44. |
|17.||Passey Mgone CS, Eupiwa S, Suve N, Tiwara S, Eupiwa T, Clegg A, et al. Community based study of sexually transmitted diseases in rural women in the high lands of Papua new Guinea, Prevalence and risk factors. Sex Transm Inf 1998;74:120-7. |
|18.||Nair D, Bhalla P, Mathur MD. Comparison of enzyme Immunoassay and direct fluorescent antibody test for the detection of Chlamydia trachomatis in non gonococcal urethritis. Indian J Med Microbiol 1999;174:184-6. |
|19.||Sturm-Ramirez K, Hunter B, Diop K, Ibruhima N. Molecular epidemiology of genital Chlamydia trachomatis infection in high risk women in Senegal. West Africa J Clin Microbiol 2002;38:138-45. |
|20.||Aseffa A, Ishak A, Stevens R, Fergussen E, Giles M, Yohannes G, et al. Prevalence of HIV, syphilis and genital Chlamydia infection among women in North-West Ethiopia. Epidemiol Infect 1998;120:171-7. |
|21.||Alarape AI, Olapegba PO, Chovwen CO. Condom use among students: The influence condom self-efficacy, social norms and affective attitude toward condom. J Soc Sci 2008;17:237-41. |
|22.||Sowya B, Rajen dran P, Krishnan S, Joyee AG, Rajesh H, Rajesh PK, et al. Prevalence of Chlamydia trachonatis and Neisseria gonorrhoea genital infections in the apparently healthy population of Sringen (Karnataka) by a coamplification PCR assay. Indian J Med Microbiol 2001;19:228-9. |
[Table 1], [Table 2], [Table 3], [Table 4]
|This article has been cited by|
||Prevalence and predictors of urinary/anal incontinence after vaginal delivery: prospective study of Nigerian women
| ||Kingsley Chukwu Obioha,Emmanuel Onyebuchi Ugwu,Samuel Nnamdi Obi,Cyril Chukwudi Dim,Theophilus Chimezie Oguanuo |
| ||International Urogynecology Journal. 2015; 26(9): 1347 |
|[Pubmed] | [DOI]|
||Weight Gain in Pregnancy, Maternal Age and Gestational Age in Relation to Fetal Macrosomia
| ||Yi Li,Qi-Fei Liu,Dan Zhang,Ying Shen,Kui Ye,Han-Lin Lai,Hai-Qing Wang,Chuan-Lai Hu,Qi-Hong Zhao,Li Li |
| ||Clinical Nutrition Research. 2015; 4(2): 104 |
|[Pubmed] | [DOI]|
||Seroprevalence and Risk Factors ofChlamydiaInfection in Domestic Rabbits (Oryctolagus cuniculus) in China
| ||Xiaoting Ni,Siyuan Qin,Zhilong Lou,Hongrui Ning,Xiaolin Sun |
| ||BioMed Research International. 2015; 2015: 1 |
|[Pubmed] | [DOI]|
||Ignorance aboutChlamydiacompared to gonorrhea infection among sexually active people in Nigeria
| ||N.C. Oreh,O.I. Ekwunife |
| ||International Journal of Health Promotion and Education. 2015; : 1 |
|[Pubmed] | [DOI]|
||The utility of ultrasound in late pregnancy compared with clinical evaluation in detecting small and large for gestational age fetuses in low-risk pregnancies
| ||Ahmed Al-Amin,Tania Hingston,Peter Mayall,Edward Araujo Júnior,Costa Fabrício Da Silva,Deborah Friedman |
| ||Journal of Maternal-Fetal and Neonatal Medicine. 2014; : 1 |
|[Pubmed] | [DOI]|
||Risk Factors for Macrosomia
| ||Elie Nkwabong,Guilherme Roger Nzalli Tangho |
| ||The Journal of Obstetrics and Gynecology of India. 2014; |
|[Pubmed] | [DOI]|
||The prevalence of Chlamydia trachomatis infection among infertile males and its association with abnormal semen characteristics in Delta State, Nigeria
| ||Osazuwa, F. and Aiguobarueghian, O.I. and Alekwe, L. and Imade, P.E. and Ibadin, K.O. and Aberare, L.O. |
| ||Tanzania Journal of Health Research. 2013; 15(2) |